Primary entity: GBB (gamma-butyrobetaine)Also known as: γ-butyrobetaine; gamma-butyrobetaine; GBB ethyl ester (supplement form); pre-carnitine / PreCar (folk)Class: performance-adjacent literacy (see page)Cluster: Performance-adjacent
GBB (γ-butyrobetaine) is the immediate biosynthetic precursor to L-carnitine in endogenous carnitine synthesis, converted by γ-butyrobetaine dioxygenase (BBOX). It appears in some pre-workout / “super carnitine” marketing as GBB or GBB ethyl ester. It is not a peptide, not a SARM, and not an FDA-approved weight-loss or endurance drug. Human performance evidence is thin relative to marketing; gut-microbial metabolism to TMA/TMAO is a separate cardiovascular-literacy theme in the literature.
GBB is not a peptide. It is a trimethylated amino-acid-related metabolite in the carnitine pathway. Do not confuse with meldonium (mildronate), which inhibits carnitine synthesis and can raise GBB — different drug story.
Marketed in the U.S. primarily as a dietary-supplement ingredient (quality and claims vary; FDA does not pre-approve supplements). Not an approved prescription performance medicine. WADA focus historically sits more on related metabolic agents (e.g., meldonium) than on GBB itself — athletes should still verify GlobalDRO / current list for any specific product.
Key takeaways
- Not a peptide — carnitine-pathway precursor (γ-butyrobetaine).
- Converted to L-carnitine via BBOX; “pre-carnitine” is folk branding.
- Supplement marketing ≥ human sports RCT evidence — treat claims cautiously.
- Microbiome can route GBB toward TMA/TMAO pathways studied in CV research — literacy, not panic copy.
- No dosage chart; sweating folklore ≠ proven fat-loss protocol.
Questions this page answers
Next questions we answer on this page (curiosity / AI-gap map):
- What is GBB?
- Aliases / ester forms
- Classification
- What it is NOT
- Mechanism (carnitine / BBOX)
- Evidence ladder
- What has been studied
- Safety / TMAO literacy
- Regulatory snapshot
- Why no dosages
- Related compounds
- Who for / not for
Who is this profile for — and who is it not for?
For: readers decoding “GBB / pre-carnitine” labels next to peptides and stimulants in pre-workout aisles.
Not for: anyone seeking a sweat protocol, fat-loss stack chart, or medical advice.
What is GBB?
γ-Butyrobetaine (GBB) is the last precursor before L-carnitine in the endogenous pathway that starts from lysine/methionine metabolism. Supplement products often use GBB ethyl ester for formulation/marketing reasons — ester ≠ proof of superior outcomes.
Classic nutrition research (Rebouche lineage) studied dietary GBB effects on tissue carnitine in animals and limited human precursor work; modern sports marketing amplifies those threads.
| Chemistry class | Carnitine precursor / pathway metabolite |
|---|---|
| Peptide? | No |
| Common supplement form | GBB ethyl ester (verify label) |
| U.S. status | Supplement-ingredient context (not a drug approval) |
| Key confusion | ≠ meldonium; ≠ carnitine itself |
Also known as
- γ-butyrobetaine / gamma-butyrobetaine / GBB — primary names.
- GBB ethyl ester — frequent sports-supplement form.
- Pre-carnitine / PreCar
Online nickname— marketing shorthand. - Mis-tags: “GBB peptide,” “GBB SARM” — category errors.
GBB is a precursor. Raising precursor availability is not identical to ingesting L-carnitine, and microbiome side-routes (TMA/TMAO) add complexity carnitine labels alone do not capture.
How is GBB classified?
Endogenous metabolite / dietary-supplement ingredient in consumer markets — not a peptide drug, not a SARM, not an approved obesity medicine. Performance-adjacent cluster placement is SERP-driven.
What is GBB not?
| GBB is not… | Why that matters |
|---|---|
| A peptide | Metabolite / small molecule |
| A SARM or steroid | Different pathway entirely |
| Meldonium (mildronate) | Meldonium inhibits carnitine synthesis; different agent |
| Proven “super carnitine” drug | Marketing > sports RCT maturity |
| Something we dose or source | Refusal |
How is GBB thought to work?
Endogenous conversion GBB → L-carnitine via BBOX supports fatty-acid transport into mitochondria in classical biochemistry. Supplement narratives claim amplified carnitine pools and thermic/sweat effects — evidence quality varies and should not be treated as labeled drug efficacy. Separately, gut microbes can metabolize carnitine-pathway trimethylamines toward TMA → hepatic TMAO, a pathway studied in atherosclerosis research.
What human vs animal vs label evidence exists?
| Evidence type | What exists (summary) | Maturity |
|---|---|---|
| Human precursor studies | Limited historical dietary-precursor work (e.g., Rebouche-era) showing carnitine pool shifts at research intakes | Human Thin / old |
| Animal | Biosynthesis / tissue carnitine / vascular GBB models | Animal |
| Microbiome / CV pathway | GBB as intermediate toward TMA/TMAO in mechanistic papers | Human/Animal pathway literacy |
| Sports RCTs for “fat loss” | Not established as robust labeled indication | None / weak marketing layer |
| Approved U.S. drug label | None for GBB as performance drug | None |
This page does not invent sweat-rate or fat-loss effect sizes.
What has GBB been studied for?
Nutrition science: carnitine biosynthesis and tissue pools. Mechanistic CV research: GBB/TMAO pathway biology. Sports-supplement marketing: thermogenesis / “carnitine amplifier” claims. Studied pathway ≠ proven consumer outcome.
What safety topics come up?
As a supplement ingredient, products vary in identity and dose accuracy. Pathway literacy includes TMAO / cardiovascular research themes for carnitine-related trimethylamines — association and mechanism papers are not the same as proving GBB supplements cause heart disease; still, “harmless natural precursor” is too simplistic. High research intakes historically noted autonomic-feeling effects (e.g., sweating/salivation anecdotes in older literature) — not a protocol. Not medical advice.
What is GBB's regulatory status?
- U.S.: Sold in dietary-supplement space; FDA does not pre-approve supplements for safety/efficacy like drugs. Structure/function claims are manufacturer-responsible.
- WADA: Confirm any specific branded product on GlobalDRO; GBB is not the same entity as meldonium
- Label accuracy: Treat multi-ingredient pre-workouts as stimulant stacks first; GBB is rarely the sole active story.
Why doesn't this page include a dosage chart?
No approved performance-drug label; “GBB dosage for fat loss” queries seek self-experimentation charts. We refuse protocol publication.
Related lab literacy
Not a peptide reconstitution topic. See What are peptides?.
Related compounds and comparisons
- Cardarine / SR9009 — other non-peptide metabolic/performance literacy pages.
- Eria Jarensis — stimulant-adjacent pre-workout literacy.
- Tesofensine — investigational weight-loss small molecule (not a peptide).
Frequently asked questions
Is GBB a peptide?
No. It is γ-butyrobetaine, a carnitine-pathway precursor.
Is GBB the same as carnitine?
No. It is converted to L-carnitine by BBOX; related but not identical.
Is GBB the same as meldonium?
No. Meldonium inhibits carnitine synthesis and can elevate GBB — different pharmacology and doping history.
Does GBB burn fat?
Marketing claims outrun robust sports RCT proof. Treat as unproven consumer claim territory.
Why discuss TMAO?
Mechanistic papers place GBB on a gut-microbial route toward TMA/TMAO studied in CV research — literacy, not a diagnosis.
Why no dosage chart?
YMYL / self-experimentation refusal for performance protocols.
Not a peptide, not medical advice, not a buy guide. Disclaimer..
Sources
The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.
- Anti-doping (related agent) World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2026. Accessed November 10, 2026. Confirm the current list and GlobalDRO before relying on sport status. Gamma-butyrobetaine (GBB) was not named on the 2026 list page we checked. Meldonium, which acts on the carnitine pathway, is listed under S4.4.3 — do not treat GBB supplements as the same substance, and do not assume they are permitted.
- Regulatory literacy U.S. Food and Drug Administration. FDA 101: Dietary Supplements. Accessed November 10, 2026. GBB is marketed as a carnitine precursor; it is not an FDA-approved performance drug. This page does not invent human performance-trial results.
- Written by
- Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
- Published · Updated
- Oct 7, 2026 · Oct 7, 2026 · Regulatory and sport-status wording checked November 10, 2026 against current FDA labels and the 2026 WADA Prohibited List · How we source & update
Educational disclaimer: Educational only. GBB is not a peptide. No dosing or buy links. We don't sell peptides. Read our full disclaimers.